Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance

Go back to Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 4.25 +0.08 (1.92%)
Previous Close $4.17    52 Week High $16.89 
Open $4.27    52 Week Low $7.35 
Day High $4.30    P/E N/A 
Day Low $4.23    EPS $-2.35 
Volume 282,744